Whittier Trust CO Incyte Corp Transaction History

Whittier Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$66.18 - $83.18 $2,647 - $3,327	40 New	40 $3,000
Q1 2020 Apr 27, 2020	SELL	$63.18 - $85.97 $2,274 - $3,094	-36 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$73.04 - $95.72 $2,629 - $3,445	36 New	36 $3,000
Q4 2017 Feb 07, 2018	SELL	$93.56 - $116.6 $2,339 - $2,915	-25 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$109.15 - $138.27 $2,728 - $3,456	25	25 $3,000

666

187M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.